Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report)’s stock price dropped 3.8% during trading on Monday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares traded hands during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Price Performance
The stock has a market capitalization of C$52.28 million and a price-to-earnings ratio of -0.37. The company has a debt-to-equity ratio of 35.45, a quick ratio of 2.61 and a current ratio of 2.97. The company has a 50 day moving average of C$0.26 and a 200 day moving average of C$0.26.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
See Also
- Five stocks we like better than Emerald Health Therapeutics
- Roth IRA Calculator: Calculate Your Potential Returns
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- How to Calculate Stock Profit
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
